NCT00423709View on ClinicalTrials.gov

Allogeneic Blood Stem Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Hodgkin's Disease
Interventions
PROCEDURE

Allogeneic Blood Stem Cell Transplantation

DRUG

Fludarabine

DRUG

Melphalan

Trial Locations (1)

77030

U.T. M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00423709 - Allogeneic Blood Stem Cell Transplantation | Biotech Hunter | Biotech Hunter